Tolerability and Immunogenicity of Fluval P Monovalent Influenza Vaccine

NCT01010893 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
355
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Fluart Innovative Vaccine Ltd, Hungary